Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Submitted by
admin
on October 31, 2009 - 10:45am
Source:
Yahoo/PR NewsWire
News Tags:
Byetta
Amylin
Eli Lilly
type 2 diabetes
Headline:
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Do Not Allow Advertisers to Use My Personal information
